INHIB1X

Overview

INHIB1X is a tetracyclic MAPKAP-K2 ( MK2 ) inhibitor with an IC 50 of 0.02 μM. INHIB1X inhibits LPS-induced TNFα release in human peripheral blood mononuclear cells (hPBMCs). INHIB1X suppresses the phosphorylation of hsp27 in Anisomycin-stimulated THP-1 cells. INHIB1X can be used for the research of inflammatory and tumor diseases.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > MAPKAPK2 (MK2)

Product Information

• Catalog No.: HY-182596
• CAS No.: 1105659-16-2
• Molecular Formula: C23H21FN4O
• Molecular Weight: 388.44
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source